छोड़कर सामग्री पर जाएँ

Ashok Leyland skids 2% on profit-booking, subsidiary secures $50-mn funding

The capital infusion will empower the company to bolster its research and development capabilities, leveraging organic growth and strategic acquisitions.

Read More

​ The capital infusion will empower the company to bolster its research and development capabilities, leveraging organic growth and strategic acquisitions. The capital infusion will empower the company to bolster its research and development capabilities, leveraging organic growth and strategic acquisitions.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी